SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves quarterly results beat expectations and lifted its outlook, while management emphasized strong AI-compute demand and a growing backlog, prompting a sharp bullish reaction and short-squeeze speculation. Traders remain divided over whether customer prepayments and secured financing ease concerns about heavy debt, interest costs, and cash burn.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists Q3 results and earnings-call outlook are driving attention, particularly the Samsung and Micron licensing agreements and the expected recurring revenue they bring. Traders are divided over the headline earnings versus analyst expectations, with bullish discussion focused on the stronger business outlook and margins; hopes for an SK Hynix deal or Nasdaq listing remain speculation.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigettis quarterly results missed expectations, with weak revenue reinforcing concerns about cash burn and the pace of commercialization. Traders are largely bearish on valuation and near-term prospects, while some long-term bulls point to quantum technology progress and government support.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Bridgewater, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotechs quarterly update triggered a sharp selloff as management said U.S. CARVYKTI growth in earlier treatment lines is slower than expected and market expectations for future growth may be optimistic. Some traders view the reaction as an overdone sell-the-news move, pointing to continued global growth and upcoming LB2501 data, while others are focused on the softer demand outlook.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics strong Q3 results and another full-year revenue guidance increase sparked attention, with traders debating whether the subsequent pullback reflects profit-taking or doubts about the rallys staying power. Bulls point to accelerating Eversense growth, while skeptics cite continuing losses, cash needs and management concerns.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebiuss Q3 earnings are the central focus, with traders interpreting CoreWeaves strong results as evidence of resilient AI-compute demand and hoping for a similar lift across neocloud stocks. Optimism about growth and a possible short squeeze is tempered by concerns over capital spending, financing, and the stocks recent weakness.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Anthropics anticipated IPO and related filing news are driving attention to DXYZ as a public-market proxy for its private holdings. Traders are divided between expecting IPO-related gains and pointing to the muted share-price response, valuation uncertainty, and DXYZs discount to NAV and dilution concerns.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors Q3 update that deramiocels application is in final review has focused attention on the FDAs Nov. 22 decision, particularly for the Duchenne muscular dystrophy upper-limb indication. Many traders read managements confidence and launch preparations as encouraging, while others stress that approval remains uncertain and debate whether cardiac benefits could be included in the label or pursued later.

Digital Turbine, Inc. engages in mobile growth platform solutions for advertisers, publishers, carriers, and device original equipment manufacturers. It operates through the following segments: On Device Solutions and App Growth Platform. The On Device Solutions segment consists of products and services that simplify the discovery and delivery of mobile apps and content media for device end users. The App Growth Platform segment provides Advertising Solutions and Ad Monetization Solutions. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbines earnings beat and higher revenue outlook were overshadowed by gross-margin compression and unchanged EBITDA guidance, triggering a sharp selloff. Traders debate whether the decline overstates a temporary margin squeeze or reflects deeper concerns about profitability, debt, and accounting controls.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers disappointing quarterly resultsespecially falling sequential subscribers, sharply weaker margins and reduced profitability guidancehave driven a steep selloff. Bears question whether growth can translate into profits, while bulls see the decline as overdone and point to international expansion, the Lilly partnership and upcoming Peptides+ as potential longer-term opportunities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
